Get started
Inotiv, Inc.Inotiv, Inc.Inotiv, Inc.

Inotiv, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

NOTV chart


Full chart

NOTV upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪151.91 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.19 USD
Net income (FY)
‪−108.44 M‬ USD
Revenue (FY)
‪490.74 M‬ USD
Shares float
‪27.05 M‬
Beta (1Y)
4.35

Employees


Employees (FY)
‪2.08 K‬
Change (1Y)
+120 +6.14%
Revenue / Employee (1Y)
‪236.50 K‬ USD
Net income / Employee (1Y)
‪−52.26 K‬ USD

About Inotiv, Inc.


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Robert W. Leasure
Website
inotivco.com
Headquarters
West Lafayette
Founded
1974
FIGI
BBG000BX15W6
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NOTV news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

NOTV highest yielding bonds


NOTV5483717
Inotiv, Inc. 3.25% 15-OCT-2027
Yield to maturity
76.70%
Maturity date
Oct 15, 2027

Explore more bonds 

Frequently Asked Questions


The current price of NOTV is 4.32 USD — it has decreased by −8.96% in the past 24 hours. Watch Inotiv, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Inotiv, Inc. stocks are traded under the ticker NOTV.
NOTV stock has risen by 6.40% compared to the previous week, the month change is a 21.01% rise, over the last year Inotiv, Inc. has showed a 20.00% increase.
We've gathered analysts' opinions on Inotiv, Inc. future price: according to them, NOTV price has a max estimate of 10.00 USD and a min estimate of 4.00 USD. Watch NOTV chart and read a more detailed Inotiv, Inc. stock forecast: see what analysts think of Inotiv, Inc. and suggest that you do with its stocks.
NOTV reached its all-time high on Nov 19, 2021 with the price of 60.66 USD, and its all-time low was 0.60 USD and was reached on Mar 9, 2009. View more price dynamics on NOTV chart.
See other stocks reaching their highest and lowest prices.
NOTV stock is 12.56% volatile and has beta coefficient of 4.35. Track Inotiv, Inc. stock price on the chart and check out the list of the most volatile stocks — is Inotiv, Inc. there?
Today Inotiv, Inc. has the market capitalization of ‪151.91 M‬, it has increased by 14.68% over the last week.
Yes, you can track Inotiv, Inc. financials in yearly and quarterly reports right on TradingView.
Inotiv, Inc. is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
NOTV earnings for the last quarter are −0.73 USD per share, whereas the estimation was −0.97 USD resulting in a 25.13% surprise. The estimated earnings for the next quarter are −0.74 USD per share. See more details about Inotiv, Inc. earnings.
Inotiv, Inc. revenue for the last quarter amounts to ‪130.42 M‬ USD, despite the estimated figure of ‪116.94 M‬ USD. In the next quarter, revenue is expected to reach ‪122.72 M‬ USD.
NOTV net income for the last quarter is ‪−18.89 M‬ USD, while the quarter before that showed ‪−26.09 M‬ USD of net income which accounts for 27.58% change. Track more Inotiv, Inc. financial stats to get the full picture.
No, NOTV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has ‪2.08 K‬ employees. See our rating of the largest employees — is Inotiv, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Inotiv, Inc. EBITDA is ‪−12.62 M‬ USD, and current EBITDA margin is 1.50%. See more stats in Inotiv, Inc. financial statements.
Like other stocks, NOTV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Inotiv, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Inotiv, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Inotiv, Inc. stock shows the sell signal. See more of Inotiv, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.